Recent Company News

• 10:59 AM ET Oct 06, 2026
  

  StreetAccount Sector Summary - China Healthcare September Recap

• 06:22 AM ET Oct 01, 2026
  

  Gland Pharma to acquire 60% stake in Novelstar Pharma for $21.0M (INR2.02B) (INR 2876.00, 0.00)

• 09:21 PM ET Sep 30, 2026
  

  StreetAccount China Pre Market Update: China ADRs overnight +0.60%; Hang Seng Futures (0.38%)

• 05:17 AM ET Sep 30, 2026
  

  Fosun Pharmaceutical co-president Wenjie Zhang resigns for personal reasons, effective today (HK$18.47, 0.00)

• 04:53 AM ET Sep 23, 2026
  

  Shanghai Henlius Biotech signs global TCE drug collaboration with Amberstone Biosciences (HK$62.50, 0.00)

• 11:26 PM ET Sep 20, 2026
  

  StreetAccount Summary - Trading higher/lower: China mid-morning

• 01:32 PM ET Sep 17, 2026
  

  Health Canada authorizes Pfizer and BioNTech's Omicron XFG-adapted COVID-19 Vaccine ($27.64, +0.18)

• 07:42 PM ET Sep 13, 2026
  

  StreetAccount Summary - Notable APAC repurchase announcements: Week of 13-Sep

• 09:17 PM ET Sep 08, 2026
  

  StreetAccount China Pre Market Update: China ADRs overnight (1.73%); Hang Seng Futures (1.56%)

• 03:53 AM ET Sep 07, 2026
  

  Fosun International's Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record